Skip to main content

Table 3 Individual immunohistochemical parameters

From: 18F–FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma

Number

Groupa

CD31

Ki-67

1

T

166

4433

2

T

83

5831

3

T

212

3189

4

T

129

2649

5

T

222

2832

6

T

182

3820

7

T

79

4033

8

T

105

2912

9

T

100

2227

10

T

151

4306

11

T

179

4210

12

T

151

4177

Mean ± SDb

T

147 ± 48

3718 ± 998

13

C

271

6801

14

C

336

6349

15

C

447

6489

16

C

191

3799

17

C

307

4562

18

C

358

4582

19

C

261

3379

20

C

284

5718

21

C

132

6824

Mean ± SDb

C

287 ± 92

5389 ± 1332

  1. aT = therapy group; C = control group
  2. bSD = standard deviation